project id: TCGA-OV; case submitter id: TCGA-13-1509; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.7; spectrophotometer method: UV Spec; age at index: 64; days to birth: -23481; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 23481; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2438.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 1.7; preservation method: Unknown; shortest dimension: 0.4; sample id: 832fbf68-76dc-47f7-b0ac-257d77d69bdf; sample submitter id: TCGA-13-1509-01A; portion id: 635eb50e-6d68-4f01-aca7-57cc01c4ac11; portion submitter id: TCGA-13-1509-01A-01; percent necrosis: 5.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0;